WO2011152884A9 - 14 gene signature distinguishes between multiple myeloma subtypes - Google Patents
14 gene signature distinguishes between multiple myeloma subtypes Download PDFInfo
- Publication number
- WO2011152884A9 WO2011152884A9 PCT/US2011/001020 US2011001020W WO2011152884A9 WO 2011152884 A9 WO2011152884 A9 WO 2011152884A9 US 2011001020 W US2011001020 W US 2011001020W WO 2011152884 A9 WO2011152884 A9 WO 2011152884A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- multiple myeloma
- gene signature
- signature distinguishes
- subtypes
- myeloma subtypes
- Prior art date
Links
- 101150082072 14 gene Proteins 0.000 title 1
- 208000034578 Multiple myelomas Diseases 0.000 title 1
- 206010035226 Plasma cell myeloma Diseases 0.000 title 1
- 230000004547 gene signature Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39691710P | 2010-06-04 | 2010-06-04 | |
US61/396,917 | 2010-06-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011152884A2 WO2011152884A2 (en) | 2011-12-08 |
WO2011152884A9 true WO2011152884A9 (en) | 2012-04-12 |
Family
ID=45067222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/001020 WO2011152884A2 (en) | 2010-06-04 | 2011-06-06 | 14 gene signature distinguishes between multiple myeloma subtypes |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2011152884A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016066665A1 (en) * | 2014-10-28 | 2016-05-06 | Institut Gustave Roussy | Improved treatments of cancer resistant to taxoids |
ES2916450T3 (en) * | 2017-07-21 | 2022-07-01 | Liquid Biopsy Res Llc | Method for the detection of plasma cell dyscrasia |
-
2011
- 2011-06-06 WO PCT/US2011/001020 patent/WO2011152884A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2011152884A2 (en) | 2011-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2535184A4 (en) | Sheet for forming hard coating | |
EP2678969A4 (en) | Digital signatures | |
EP2670019A4 (en) | Shovel | |
WO2012088388A9 (en) | Treating multiple myeloma | |
EP2670020A4 (en) | Shovel | |
EP2669917A4 (en) | Shovel | |
EP2559538A4 (en) | Calender | |
AU2010100385A4 (en) | Eldeap | |
WO2011152884A9 (en) | 14 gene signature distinguishes between multiple myeloma subtypes | |
AU2010101325A4 (en) | MobileVBM | |
AU2010101066A4 (en) | Tropidry | |
AU2011900720A0 (en) | Skirting | |
AU2010902355A0 (en) | Skirting | |
AU2011100516A4 (en) | Arbitrage | |
AU2011100323A4 (en) | TagOwna Systems | |
EP2526155A4 (en) | Can coatings | |
AU2010101200A4 (en) | Ileo-alert | |
AU2010101315A4 (en) | AcroSafe | |
AU2010101195A4 (en) | Vehiclecctv | |
AU2010100716A4 (en) | Whatsthatbillboard | |
AU2010100625A4 (en) | TreeCups | |
AU2010100344A4 (en) | Icbd | |
AU2011900168A0 (en) | TSJ Block | |
AU2011901551A0 (en) | Darta scann | |
AU2010900342A0 (en) | Trade new deal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11790117 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11790117 Country of ref document: EP Kind code of ref document: A2 |